Publications by authors named "Jochen Willner"

Claim this Profile
I
Impact of target volume and dose concepts on the outcomes of prostate cancer patients treated with stereotactic body radiotherapy for spinal metastases - a European multicenter cohort study.
Isabell Seiler, Sebastian Schäfer, Camilla von Wachter, Panagiotis Balermpas, Marek Slavik, Jochen Willner

Radiother Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Structural, procedural, and personnel requirements for provision of radiation oncology and radiation therapy services in Germany in 2023-a position paper of the German Society of Radiation Oncologists (DEGRO)].
Rainer Fietkau, Ulrike Höller, Mechthild Krause, Cordula Petersen, Michael van Kampen, Jochen Willner

Strahlenther Onkol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent chemoradiation therapy with docetaxel/cisplatin followed by docetaxel consolidation therapy in inoperable stage IIIA/B non-small-cell lung cancer: results of a phase I study.
Rudolf M Huber, Astrid Borgmeier, Michael Flentje, Jochen Willner, Michael Schmidt

Clin Lung Cancer· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of total mesorectal excision on the outcome of rectal cancer after standardized postoperative radiochemotherapy: do randomized studies translate into clinical routine?
Ludwig Keilholz, Mesud Mese, Klaus Henneking, Jochen Willner

Strahlenther Onkol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns of care in the radiotherapy of prostate cancer in Northern Bavaria 1998-2000.
Dirk Vordermark, Dorothee Marold, Susanne Wirth, Ludwig Keilholz, Klaus Pfändner, Jochen Willner

Strahlenther Onkol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group.
Rudolf M Huber, Michael Flentje, Michael Schmidt, Barbara Pöllinger, Helga Gosse, Jochen Willner

J Clin Oncol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucose requirement for hypoxic accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha).
Dirk Vordermark, Peter Kraft, Astrid Katzer, Tobias Bölling, Jochen Willner

Cancer Lett· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is survival following post-operative radiotherapy in pN1-non-small cell lung cancer reduced? Results of a multivariate analysis.
Jochen Willner, Viktor Wiens, Manfred Jachmann, Imme Haubitz, Michael Flentje

Oncol Rep· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent rectal cancer within the pelvis. A multicenter analysis of 123 patients and recommendations for adjuvant radiotherapy.
Stefan Höcht, Riad Hammad, Hans-Joachim Thiel, Thomas Wiegel, Alessandra Siegmann, Jochen Willner

Strahlenther Onkol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction chemotherapy with paclitaxel and cisplatin and CT-based 3D radiotherapy in patients with advanced laryngeal and hypopharyngeal carcinomas--a possibility for organ preservation.
Leo Pfreundner, Florian Hoppe, Jochen Willner, Verena Preisler, Klaus Bratengeier

Radiother Oncol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy.
Jochen Willner, Andre Jost, Kurt Baier, Michael Flentje

Strahlenther Onkol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secretory activity and cell cycle alteration of alveolar type II cells in the early and late phase after irradiation.
Jochen Willner, Dirk Vordermark, Michael Schmidt, Andreamaria Gassel, Michael Flentje

Int J Radiat Oncol Biol Phys· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer.
Jochen Willner, Kurt Baier, Ekaterini Caragiani, Axel Tschammler, Michael Flentje

Int J Radiat Oncol Biol Phys· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis